ValuEngine Lowers Endo International (NASDAQ:ENDP) to Sell

Endo International (NASDAQ:ENDP) (TSE:ENL) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday, ValuEngine reports.

Other equities analysts have also recently issued reports about the stock. Mizuho reissued a “hold” rating and issued a $6.00 price objective on shares of Endo International in a research note on Wednesday, August 7th. BidaskClub raised shares of Endo International from a “strong sell” rating to a “sell” rating in a research note on Friday, October 18th. Royal Bank of Canada reissued a “hold” rating and issued a $6.00 price objective on shares of Endo International in a research note on Thursday, August 8th. Finally, Morgan Stanley set a $2.00 price objective on shares of Endo International and gave the company a “sell” rating in a research note on Friday, August 9th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $7.78.

Endo International stock traded up $0.10 during trading on Thursday, reaching $4.33. The stock had a trading volume of 5,829,800 shares, compared to its average volume of 5,703,535. The stock has a market cap of $1.01 billion, a PE ratio of 1.50 and a beta of 1.41. The business has a 50 day moving average price of $4.02 and a 200 day moving average price of $4.34. Endo International has a 52-week low of $1.97 and a 52-week high of $13.75.

Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.07. The company had revenue of $729.00 million for the quarter, compared to analysts’ expectations of $709.01 million. Endo International had a negative net margin of 16.89% and a negative return on equity of 99.08%. Endo International’s revenue was down 2.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.71 EPS. As a group, sell-side analysts expect that Endo International will post 2.19 EPS for the current fiscal year.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

In other Endo International news, Director Roger H. Kimmel sold 25,000 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $4.09, for a total transaction of $102,250.00. Following the sale, the director now directly owns 123,309 shares in the company, valued at approximately $504,333.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by insiders.

Several institutional investors have recently added to or reduced their stakes in the stock. Diamond Hill Capital Management Inc. boosted its position in shares of Endo International by 13.6% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,231,523 shares of the company’s stock worth $3,953,000 after buying an additional 147,282 shares in the last quarter. Rhumbline Advisers boosted its position in shares of Endo International by 8.0% in the 3rd quarter. Rhumbline Advisers now owns 553,157 shares of the company’s stock worth $1,776,000 after buying an additional 40,894 shares in the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Endo International by 14.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 50,690 shares of the company’s stock worth $163,000 after buying an additional 6,434 shares in the last quarter. Meeder Asset Management Inc. boosted its position in shares of Endo International by 32.2% in the 3rd quarter. Meeder Asset Management Inc. now owns 50,089 shares of the company’s stock worth $160,000 after buying an additional 12,202 shares in the last quarter. Finally, United Services Automobile Association boosted its position in shares of Endo International by 6.4% in the 2nd quarter. United Services Automobile Association now owns 218,890 shares of the company’s stock worth $902,000 after buying an additional 13,126 shares in the last quarter. Institutional investors and hedge funds own 95.20% of the company’s stock.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Read More: Can systematic risk be avoided?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Endo International (NASDAQ:ENDP)

Leave a Reply

Your email address will not be published. Required fields are marked *

*